RedChip Companies
|
Weekly Newsletter
|
|
BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory
|
BullFrog AI (Nasdaq: BFRG), a digital technology company using machine learning to usher in a new era of precision medicine, announced the expansion of its worldwide license agreement with the Johns Hopkins Applied Physics Laboratory (APL), in Laurel, Maryland, for use of patented technology powering the Company’s bfLEAP™ platform, an AI-driven platform for analyzing drug development data to potentially make life-saving therapies and treatments available to patients more quickly.
For more information, visit www.bullfrogai.com
|
Zomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Services
Zomedica (NYSE American: ZOM), a leading innovator in veterinary medicine offering diagnostic and therapeutic products for companion animals, announced the launch of the revolutionary TRUVIEW digital microscopy platform, featuring the proprietary TRUprep system that automatically prepares slides, along with LiquiView liquid lens technology that provides best-in-class images.
|
Genius Group Announces 119% Revenue Growth for Full Year 2022, Expansion of Pro Forma Gross Margin to 53%
Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, announced results for the year ended December 31, 2022, with revenue up 119% to $18.2 million.
|
|
|
Lantern Pharma Leverages AI Platform, RADR®, to Develop Breakthrough Antibody Drug Conjugates (ADCs) in Collaboration with Bielefeld University
Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, announced it will be leveraging its AI platform, RADR®, in a research collaboration with Bielefeld University (Bielefeld, Germany) to develop antibody-drug conjugates (ADCs) with high therapeutic and antitumor potential.
|
Graphex Technologies Receives Environmental Permit and Provides Updates on Michigan Developments
Graphex Technologies, LLC, a wholly owned subsidiary of Graphex Group Limited (collectively “Graphex”) (NYSE American: GRFX | HKSE: 6128) and a global leader in mid-stream processing of natural graphite for use in Lithium-ion (Li-ion) powered batteries, shared updates on its Warren processing facility and other developments in Michigan, highlighting its progress in creating a stable domestic supply chain to meet unprecedented national demand for graphite.
|
|
|
Upcoming Events |
|
|
|
NASDAQ: ARDS - Aridis Pharmaceuticals |
4:15pm Eastern |
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
11:00am Eastern |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
4:15pm Eastern |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
OTC: EBZT - Everything Blockchain |
4:15pm Eastern |
Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. |
|
|
|
|
NASDAQ: SPI - SPI Energy |
4:15pm Eastern |
SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California. |
|
|
|
|
NASDAQ: BIVI - BioVie |
4:15pm Eastern |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
OTCQB: QYOUF - QYOU Media |
4:15pm Eastern |
QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. |
|
|
Archive Events |
|
|
|
NYSE American: GNS - Genius Group |
Meeting Duration 44 minutes |
Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
NASDAQ: ALAR - Alarum Technologies |
Meeting Duration 36 minutes |
Alarum Technologies Ltd. is an Israel-based company engaged in the information security business. It controls and secures data exchange, preventing data exfiltration, leakage, malware, ransomware, and fraud. |
|
|
|
|
NASDAQ: STSS - Sharps Technology |
Meeting Duration 48 minutes |
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
NASDAQ: LTRN - Lantern Pharma |
Meeting Duration 34 minutes |
Lantern Pharma is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies. |
|
|
|
|
NASDAQ: SNGX - Soligenix |
Meeting Duration 48 minutes |
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
NASDAQ: SPI - SPI Energy |
Meeting Duration 145 minutes |
We are delighted to invite you to SPI Energy's Investor Day 2023, where you will have the chance to learn more about our strategic vision and growth plans and hear from key members of our leadership team. |
|
|
|
|
NASDAQ: BIVI - BioVie |
Meeting Duration 43 minutes |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
NASDAQ: BFRG - BullFrog AI |
Meeting Duration 35 minutes |
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. |
|
|
|
|
NASDAQ: UNCY - Unicycive Therapeutics |
Meeting Duration 28 minutes |
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
Meeting Duration 32 minutes |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
NASDAQ: GENE - Genetic Technologies Limited |
Meeting Duration 30 minutes |
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
Meeting Duration 38 minutes |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
Lesson of the Week
Learn about value investing in this week's lesson.
|
|
|
MidSouth Week in Review
Chinese imports declined 7.5% in May after being up 8.5% in April. Bitcoin dropped below 26k to its lowest level since March.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
© 2023 RedChip , All rights reserved
|
|
|
|
|